Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kusuri No Aoki HoldingsTSE:3549 +0.68%91 Debt-to-EBITDA is 2.01 as of May. 2026, which is 14% below its 10-year median of 2.35. GuruFocus rates TSE:3549 with a GF Score™ of 91/100 and a GF Value™ of 円4,304.89 (Fairly Valued). The stock has 2 warning signs investors should review. Among 478 Healthcare Providers & Services companies, Kusuri No Aoki Holdings ranks worse than 67.36% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Kusuri No Aoki Holdings's Debt-to-EBITDA or its related term are showing as below:
TSE:3549'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.25 Med: 2.35 Max: 3.64
Current: 3.64
During the past 13 years, the highest Debt-to-EBITDA Ratio of Kusuri No Aoki Holdings was 3.64. The lowest was 1.25. And the median was 2.35.
TSE:3549's Debt-to-EBITDA is ranked worse than 67.36% of 478
companies
in the Healthcare Providers & Services industry
Industry Median: 2.195
vs TSE:3549: 3.64
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Kusuri No Aoki Holdings Debt-to-EBITDA Related Terms
Kusuri No Aoki Holdings Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kusuri No Aoki Holdings Debt-to-EBITDA Competitor Comparison
For the Pharmaceutical Retailers subindustry, Kusuri No Aoki Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kusuri No Aoki Holdings Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Kusuri No Aoki Holdings's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Kusuri No Aoki Holdings's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (May. 2026) EBITDA data.
Kusuri No Aoki Holdings (TSE:3549) has a Debt-to-EBITDA of 2.01 as of May. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Kusuri No Aoki Holdings. This is 14% below median its historical median of 2.35. Over the past decade, Kusuri No Aoki Holdings' Debt-to-EBITDA has ranged from 1.25 to 3.64. According to the industry distribution chart, Kusuri No Aoki Holdings ranks #322 out of 478 companies in the Healthcare Providers & Services industry, placing it in the top 67.4%.
Is Kusuri No Aoki Holdings' Debt-to-EBITDA too high?
Kusuri No Aoki Holdings' current Debt-to-EBITDA of 2.01 is 14% below median its 10-year median of 2.35. Over the past 10 years, this metric has ranged from a low of 1.25 to a high of 3.64. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.20. Kusuri No Aoki Holdings' value of 2.01 is 8.4% below this industry median. Based on the distribution chart, Kusuri No Aoki Holdings ranks #322 out of 478 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Kusuri No Aoki Holdings has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kusuri No Aoki Holdings' Debt-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Kusuri No Aoki Holdings ranks #322 out of 478 companies for Debt-to-EBITDA. This places Kusuri No Aoki Holdings in the lower half of its industry. The industry median Debt-to-EBITDA is 2.20. Kusuri No Aoki Holdings' value of 2.01 is 8.4% below this benchmark. Historically, Kusuri No Aoki Holdings' own Debt-to-EBITDA has ranged from 1.25 to 3.64 over the past decade. While the company's 10-year median is 2.35 vs. the industry median of 2.20, Kusuri No Aoki Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.20, based on 478 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kusuri No Aoki Holdings's current Debt-to-EBITDA of 2.01 is 8.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Kusuri No Aoki Holdings. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kusuri No Aoki Holdings's current Debt-to-EBITDA is 2.01, which is 14% below median its own 10-year median of 2.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kusuri No Aoki Holdings stock overvalued right now?
Based on GuruFocus' analysis, Kusuri No Aoki Holdings (TSE:3549) is currently considered Fairly Valued. The stock's GF Value™ is 円4,304.89, compared to a current price of 円4,014.00 — trading 6.8% below its estimated fair value. The current Debt-to-EBITDA is 2.01, which is 14% below median its 10-year median of 2.35 and 8.4% below the Healthcare Providers & Services industry median of 2.20. Kusuri No Aoki Holdings' overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Kusuri No Aoki Holdings (TSE:3549), the current Debt-to-EBITDA is 2.01 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kusuri No Aoki Holdings (TSE:3549) Overvalued in 2026?
Based on GuruFocus' analysis, Kusuri No Aoki Holdings stock appears to be undervalued.
The current stock price of 円4,014.00 is trading 6.8% below its estimated GF Value™ of 円4,304.89.
GuruFocus considers Kusuri No Aoki Holdings to be Fairly Valued.
Key valuation signals for TSE:3549:
Debt-to-EBITDA: 2.01 (14% below median its 10-year median of 2.35)
GF Value™: 円4,304.89 vs. price of 円4,014.00 (6.8% below fair value)
Industry Position: 8.4% below the Healthcare Providers & Services median (#322 of 478)
No single metric tells the full story. See the TSE:3549 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kusuri No Aoki Holdings is a pharmaceutical retail chain that sells health, beauty, and cleaning supplies. The company operates stores that focus primarily on residential areas in Japan. Kusuri's business includes pharmaceutical drugs, and the company also operates a bone-marrow bank. The company breaks out its sales into four different product lines, including health, beauty, life, and dispensing. The vast majority of the company's revenue is derived from its life product category, followed by beauty products. Most of Kusuri's revenue is derived from the Hokuriku region.
91GF Score
Get the complete analysis for TSE:3549
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3549 has been successfully added to your 
